Michael A Metzger, the Chief Executive Officer of $SNDX, sold 7,412 shares of the company on 02-06-2026 for an estimated $152,835. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.4% of their shares of this class of stock. Following this trade, they now own 508,849 shares of this class of $SNDX stock.
$SNDX Insider Trading Activity
$SNDX insiders have traded $SNDX stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $SNDX stock by insiders over the last 6 months:
- MICHAEL A METZGER (Chief Executive Officer) has made 0 purchases and 2 sales selling 164,719 shares for an estimated $2,734,856.
- DENNIS PODLESAK has made 0 purchases and 3 sales selling 57,600 shares for an estimated $875,099.
- KEITH A. GOLDAN (Chief Financial Officer) sold 2,082 shares for an estimated $42,930
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SNDX Hedge Fund Activity
We have seen 121 institutional investors add shares of $SNDX stock to their portfolio, and 101 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. added 2,127,580 shares (+100.0%) to their portfolio in Q3 2025, for an estimated $32,732,818
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 1,879,523 shares (+131.2%) to their portfolio in Q3 2025, for an estimated $28,916,461
- BLACKROCK, INC. removed 1,831,663 shares (-17.5%) from their portfolio in Q3 2025, for an estimated $28,180,135
- ASSENAGON ASSET MANAGEMENT S.A. removed 1,742,402 shares (-97.7%) from their portfolio in Q4 2025, for an estimated $36,607,866
- SOFINNOVA INVESTMENTS, INC. removed 1,524,440 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $23,453,509
- MPM BIOIMPACT LLC added 1,375,674 shares (+inf%) to their portfolio in Q3 2025, for an estimated $21,164,744
- NUVEEN, LLC added 1,209,755 shares (+454.7%) to their portfolio in Q3 2025, for an estimated $18,612,080
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SNDX Analyst Ratings
Wall Street analysts have issued reports on $SNDX in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 12/09/2025
- Barclays issued a "Overweight" rating on 11/24/2025
- HC Wainwright & Co. issued a "Buy" rating on 10/27/2025
- Stifel issued a "Buy" rating on 09/10/2025
To track analyst ratings and price targets for $SNDX, check out Quiver Quantitative's $SNDX forecast page.
$SNDX Price Targets
Multiple analysts have issued price targets for $SNDX recently. We have seen 10 analysts offer price targets for $SNDX in the last 6 months, with a median target of $36.5.
Here are some recent targets:
- Mara Goldstein from Mizuho set a target price of $600.0 on 01/27/2026
- Justin Zelin from BTIG set a target price of $56.0 on 12/09/2025
- Etzer Darout from Barclays set a target price of $35.0 on 11/24/2025
- Anupam Rama from JP Morgan set a target price of $33.0 on 11/12/2025
- David Dai from UBS set a target price of $38.0 on 11/04/2025
- Andres Y. Maldonado from HC Wainwright & Co. set a target price of $40.0 on 10/27/2025
- Bradley Canino from Stifel set a target price of $44.0 on 09/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
